Pharmaceutical Business Development & Licencing (BD&L)

Extending your BD&L reach into Europe and the US

NorthPoint:Bio works with established pharmaceutical companies looking to build their portfolios and expand their presence through licencing and strategic partnerships across Europe and the US.

We work alongside existing BD&L and international development teams, providing senior-level presence and additional capability in Western markets without the immediate need to build a permanent local team.

Our work starts with the company’s portfolio priorities and growth strategy. We identify where external innovation, licencing or commercial partnerships can support those ambitions, assess the most relevant opportunities and companies, and develop a focused approach to the market.

NorthPoint:Bio then helps turn that strategy into activity: opening senior-level dialogue, developing relationships with prospective partners and supporting opportunities as they move from initial interest towards serious licencing discussions.

Strong internal capabilities. Greater international reach.

IDENTIFY

  • Market and company mapping

  • Partner and asset identification

  • Opportunity qualification

  • Commercial intelligence

  • Therapeutic landscape assessment

ENGAGE

  • Senior relationship development

  • Conference and meeting strategy

  • In-person representation

  • Meeting participation and follow-up

  • Ongoing relationship development

DEVELOP

  • Opportunity progression

  • Partner dialogue and follow-up

  • Relationship continuity

  • Local market perspective

  • Ongoing BD support

Additional reach without immediately building permanent infrastructure overseas.